Morton Collins, Director at INOVIO PHARMACEUTICALS, INC. (INO), bought 229,500 shares at $1.82 ($418K) on 2013-11-13, disclosed to the SEC on 2013-11-14.
Open-market purchase of $418k INO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.82 | 3,500 | $6K | 1.5% |
| 2 | $1.82 | 11,000 | $20K | 4.8% |
| 3 | $1.82 | 25,000 | $46K | 10.9% |
| 4 | $1.82 | 40,000 | $73K | 17.4% |
| 5 | $1.82 | 50,000 | $91K | 21.8% |
| 6 | $1.82 | 100,000 |
| $182K |
| 43.6% |
| Total | $1.82 avg | 229,500 | $418K | 100% |
| Filing → |
| INO | BUY | 2017-03-28 | $133K | — | Filing → |
| INO | BUY | 2016-06-29 | $183K | — | Filing → |
| KOPN | BUY | 2016-05-20 | $106K | — | Filing → |